TxCell raises EUR 10.5 million

Inflammation company TxCell (Nice, France) raised EUR 10.5 million ($13 million) in a series A round. Investors included Auriga Partners; AXA Private Equity; BioAm; CDC; and SPEF Venture; Inserm-Trans...